Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 07, 2012 09:00 ET | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Announces Participation at Canaccord Genuity Growth Conference

CAMBRIDGE, Mass., Aug. 7, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
July 20, 2012 09:00 ET | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals to Announce Second Quarter 2012 Financial Results on Wednesday, August 8

CAMBRIDGE, Mass., July 20, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
July 06, 2012 08:00 ET | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Announces Participation at JMP Securities Healthcare Conference

CAMBRIDGE, Mass., July 6, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
June 14, 2012 09:18 ET | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Prices Public Offering of Common Stock

CAMBRIDGE, Mass., June 14, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) ("Aegerion"), an emerging biopharmaceutical company focused on the development and commercialization of...
June 13, 2012 16:16 ET | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Announces Proposed Public Offering of Common Stock

CAMBRIDGE, Mass., June 13, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) ("Aegerion"), an emerging biopharmaceutical company focused on the development and commercialization of...
June 13, 2012 08:00 ET | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Announces Participation at Wells Fargo Securities 2012 Healthcare Conference

CAMBRIDGE, Mass., June 13, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
June 04, 2012 09:00 ET | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals to Webcast Investor Event: Challenges and Opportunities in HoFH

CAMBRIDGE, Mass., June 4, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
May 30, 2012 08:00 ET | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Announces Participation at Jefferies 2012 Global Healthcare Conference

CAMBRIDGE, Mass., May 30, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
May 29, 2012 08:00 ET | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Announces Oral Presentation of Phase III Lomitapide Data at European Atherosclerosis Society Conference

CAMBRIDGE, Mass., May 29, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...
May 02, 2012 08:00 ET | Source: Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals Announces Participation at Deutsche Bank and Bank of America Merrill Lynch Healthcare Conferences

CAMBRIDGE, Mass., May 2, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel...